Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cerebral atrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
454
|
44
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Anhedonia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
93
|
7
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Chronic pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
207
|
19
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Peripheral Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
150
|
18
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hermanski-Pudlak Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
70
|
59
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Parasitic Diseases
|
group |
Infections
|
Disease or Syndrome
|
164
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Osteoporosis
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
1098
|
182
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Osteogenesis Imperfecta
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome; Congenital Abnormality
|
90
|
91
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Harlequin Fetus
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
73
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
opioid use
|
disease |
|
Mental or Behavioral Dysfunction
|
39
|
5
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Brain atrophy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
182
|
46
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Peripheral Arterial Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
319
|
128
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Attention deficit hyperactivity disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
842
|
420
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Solvent sensitivity
|
disease |
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Refractory cancer
|
phenotype |
Neoplasms
|
Neoplastic Process
|
184
|
9
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
|
disease |
|
Disease or Syndrome
|
467
|
14
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Myopia
|
disease |
Eye Diseases
|
Disease or Syndrome
|
490
|
167
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Leishmaniasis, Visceral
|
disease |
Infections
|
Disease or Syndrome
|
197
|
22
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |